1. Mercier FE, Ragu C, Scadden DT. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol. 2011;12(1):49–60.
2. Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327–34.
3. Kumar S, Geiger H. HSC niche biology and HSC expansion ex vivo. Trends Mol Med. 2017;23(9):799–819.
4. Pinho S, Frenette PS. Haematopoietic stem cell activity and interactions with the niche. Nat Rev Mol Cell Biol. 2019;20(5):303–20.
5. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25(6):977–88.
6. Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, Kohno K, et al. The essential functions of adipo-osteogenic progenitors as the hematopoi- etic stem and progenitor cell niche. Immunity. 2010;33(3):387–99.
7. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivas- cular cells maintain haematopoietic stem cells. Nature. 2012;481 (7382):457–62.
8. Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor- expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell. 2014;15(2):154–68.
9. Omatsu Y, Seike M, Sugiyama T, Kume T, Nagasawa T. Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation. Nature. 2014;508(7497):536–40.
10. Seike M, Omatsu Y, Watanabe H, Kondoh G, Nagasawa T. Stem cell niche-specific Ebf3 maintains the bone marrow cavity. Genes Dev. 2018;32 (5–6):359–72.
11. Yao JC, Link DC. Concise review: the malignant hematopoietic stem cell niche. Stem Cells. 2017;35(1):3–8.
12. Pronk E, Raaijmakers M. The mesenchymal niche in MDS. Blood. 2019;133(10):1031–8.
13. Ladikou EE, Chevassut T, Pepper CJ, Pepper AG. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia. Br J Haematol. 2020;189(5):815–25.
14. M´endez-Ferrer S, Bonnet D, Steensma DP, Hasserjian RP, Ghobrial IM, Gribben JG, et al. Bone marrow niches in haematological malignancies. Nat Rev Cancer. 2020;20(5):285–98.
15. Cattoretti G, Schiro R, Orazi A, Soligo D, Colombo MP. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood. 1993;81(7):1726–38.
16. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. Iso- lation of bone marrow mesenchymal stem cells by anti-nerve growth fac- tor receptor antibodies. Exp Hematol. 2002;30(7):783–91.
17. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007;131(2):324–36.
18. Tormin A, Li O, Brune JC, Walsh S, Schutz B, Ehinger M, et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is corre- lated with in situ localization. Blood. 2011;117(19):5067–77.
19. Flores-Figueroa E, Varma S, Montgomery K, Greenberg PL, Gratzinger D. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodys- plastic bone marrow. Lab Invest. 2012;92(9):1330–41.
20. Pinho S, Lacombe J, Hanoun M, Mizoguchi T, Bruns I, Kunisaki Y, et al. PDGFRalpha and CD51 mark human nestin+ sphere-forming mesenchy- mal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med. 2013;210(7):1351–67.
21. Johnson RC, Kurzer JH, Greenberg PL, Gratzinger D. Mesenchymal stro- mal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival. Am J Clin Pathol. 2014;142(6):795– 802.
22. Li H, Ghazanfari R, Zacharaki D, Ditzel N, Isern J, Ekblom M, et al. Low/ negative expression of PDGFR-alpha identifies the candidate primary mes- enchymal stromal cells in adult human bone marrow. Stem Cell Rep. 2014;3(6):965–74.
23. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, et al. Isolation of functionally distinct mesenchymal stem cell subsets using anti- bodies against CD56, CD271, and mesenchymal stem cell antigen-1. Hae- matologica. 2009;94(2):173–84.
24. Newman PJ, Berndt MC, Gorski J, White GC 2nd, Lyman S, Paddock C, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247(4947):1219–22.
25. Soligo D, Delia D, Oriani A, Cattoretti G, Orazi A, Bertolli V, et al. Identi- fication of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia. 1991;5(12):1026–30.
26. Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, et al. Functionally distinct disease-associated fibroblast subsets in rheuma- toid arthritis. Nat Commun. 2018;9(1):789.
27. Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14(1):22–9.
28. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expres- sion of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006;54(4):385–95.
29. Agarwal P, Isringhausen S, Li H, Paterson AJ, He J, Gomariz A, et al. Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells. Cell Stem Cell. 2019;24(5):769– 84 e6.
30. Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU, et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell. 2012;21(4):577–92.
31. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201(8):1307–18.
32. McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, et al. Chromothriptic cure of WHIM syndrome. Cell. 2015;160(4):686–99.
33. Ghazanfari R, Li H, Zacharaki D, Lim HC, Scheding S. Human Non-he- matopoietic CD271(pos)/CD140a(low/neg) bone marrow stroma cells ful- fill stringent stem cell criteria in serial transplantations. Stem Cells Dev. 2016;25(21):1652–8.
34. Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell. 2013;13(3):285–99.
35. Decker M, Martinez-Morentin L, Wang G, Lee Y, Liu Q, Leslie J, et al. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis. Nat Cell Biol. 2017;19 (6):677–88.